Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma [Phase 1]
This clinical trial update describes a Phase 1 safety and efficacy study of an anti-B7-H3 CAR-T cell therapy for recurrent glioblastoma, spo…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma [Phase 1]
A Phase 1 study evaluating intratumoral MTX110 in patients with recurrent glioblastoma has been terminated.
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study. [NA]
A prospective study evaluating imaging techniques and biological markers to predict and identify pseudoprogression in glioblastoma, currentl…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases [NA]
This clinical trial update describes a study using advanced diffusion MRI to differentiate tumor recurrence from pseudoprogression in gliobl…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema [Phase 2]
A Phase 2 clinical trial update evaluating Salovum and SPC Flakes for brain tumor–induced edema in glioblastoma, cerebral metastases, and me…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer [NA]
This update reports the completion of a clinical trial evaluating health care coach support to reduce acute care use and costs in cancer pat…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery [Phase 2]
Phase 2 clinical trial evaluating Vebreltinib with Temozolomide for glioblastoma after surgery; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Drug Response Testing and Repurposing Using Glioblastoma Organoid
A study is recruiting to test drug responses using glioblastoma organoids. The aim is to repurpose existing drugs based on organoid response…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma [Phase 1]
A Phase 1 trial is evaluating combined intravenous plus intracranial administration of ipilimumab and nivolumab in patients with Glioblastom…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma [Phase 1]
A Phase 1 trial combining partial brain radiotherapy, temozolomide, chloroquine, and tumor treating fields for newly diagnosed glioblastoma …
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions [NA]
This update reports safety and feasibility results from a completed trial investigating MR-guided laser thermal ablation of brain lesions in…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Feasibility of the LUM Imaging System for Detection of Cancer to the Brain [NA]
A feasibility trial of the LUM Imaging System for detecting cancer in the brain has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme [Phase 2]
A Phase 2 clinical trial evaluating a vaccine therapy for newly diagnosed glioblastoma multiforme has completed, and results have been poste…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM [Phase 2]
Phase 2 study in glioblastoma comparing nivolumab plus standard-dose bevacizumab versus nivolumab plus low-dose bevacizumab; results were po…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma [Phase 1]
Phase 1 trial evaluating the addition of XS15 multi-peptide vaccination to standard postoperative radiotherapy and temozolomide in newly dia…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma [Phase 2]
Phase 2 trial evaluating a telomerase-derived universal cancer peptide vaccine for glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma [Phase 1]
Phase 1 trial evaluating adavosertib in combination with radiation therapy and temozolomide for newly diagnosed or recurrent glioblastoma; t…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Expanded Access Program for GBM Subjects
This update notes an expanded access program for glioblastoma patients sponsored by Rznomics, Inc., and it is currently available for eligib…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma [NA]
Preclinical in vitro study evaluating the antitumor activity of GD2-targeted CAR-T cells against glioblastoma.
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients [EARLY_Phase 1]
This is an early Phase 1 clinical trial registry entry evaluating the safety and efficacy of NRG-103 Injection for recurrent glioblastoma, w…
-
CLINICAL_TRIALS withdrawal · 2024-12-30Clinical Trial Update: Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma [Phase 2]
Phase 2 study evaluating tiragolumab in combination with atezolizumab for recurrent glioblastoma (IDH-wildtype) has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Oral ONC201 in Adult Recurrent Glioblastoma [Phase 2]
Phase 2 trial of oral ONC201 in adult recurrent glioblastoma was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme [Phase 1]
This update reports the completion of a Phase I trial evaluating high-dose intravenous ascorbate (vitamin C) in patients with glioblastoma.
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Hypofractionated Radiotherapy [NA]
A clinical trial evaluating hypofractionated radiotherapy for glioblastoma is currently recruiting, sponsored by The First Hospital of Jilin…
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma [Phase 1]
Phase 1 study evaluating MT027 in patients with recurrent or progressive glioblastoma. The trial is not yet recruiting.